Evaluation of innate immune signaling pathways in transformed cells

Methods in Molecular Biology

Volumn 797, Issue , 2012, Pages 217-238

  Heiber, Joshua F ^a   Barber, Glen N ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Host defense; Innate immunity; Interferon; Oncolytic; STING

Indexed keywords

ANTIVIRUS AGENT; INTERFERON; MEMBRANE PROTEIN; MPYS PROTEIN, HUMAN; ONCOLYTIC VIRUS; TOLL LIKE RECEPTOR;

ARTICLE; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; NEOPLASM; ONCOLYTIC VIROTHERAPY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIVIRAL AGENTS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC TECHNIQUES; INTERFERON TYPE I; MEMBRANE PROTEINS; NEOPLASMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 80555127439     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-340-0_15     Document Type: Chapter

References (62)

1. Barber GN. (2004) Vesicular stomatitis virus as an oncolytic vector Viral Immunol 17, 516–527.
2. Barber GN. (2005) VSV-tumor selective replication and protein translation Oncogene 24, 7710–7719.
3. Choi MK, Wang Z, Ban T, Yanai H, Lu Y, et al. (2009) A selective contribution of the RIG-I-like receptor pathway to type I interferon responses activated by cytosolic DNA Proc Natl Acad Sci USA 106, 17870–17875.
4. Yoneyama M, Fujita T. (2009) RNA recognition and signal transduction by RIG-I-like receptors Immunol Rev 227, 54–65.
5. Blasius AL, Beutler B. (2010) Intracellular toll-like receptors Immunity 32, 305–315.
6. Obuchi M, Fernandez M, Barber GN. (2003) Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity Journal of Virology 77, 8843–8856.
7. Akira S, Uematsu S, Takeuchi O. (2006) Pathogen recognition and innate immunity Cell 124, 783–801.
8. Wang L, Ligoxygakis P. (2006) Pathogen recognition and signalling in the Drosophila innate immune response Immunobiology 211, 251–261.
9. Silverman N, Maniatis T. (2001) NF-kappaB signaling pathways in mammalian and insect innate immunity Genes & Development 15, 2321–2342.
10. Leclerc V, Reichhart J-M. (2004) The immune response of Drosophila melanogaster Immunol Rev 198, 59–71.
11. Gottar M, Gobert V, Michel T, Belvin M, Duyk G, et al. (2002) The Drosophila immune response against Gram-negative bacteria is mediated by a peptidoglycan recognition protein Nature 416, 640–644.
12. Kawai T, Akira S. (2008) Toll-like receptor and RIG-I-like receptor signaling Ann N Y Acad Sci 1143, 1–20.
13. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 Nature 413, 732–738.
14. Taura M, Eguma A, Suico MA, Shuto T, Koga T, et al. (2008) p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines Molecular and Cellular Biology 28, 6557–6567.
15. Lande R, Gilliet M. (2010) Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses Ann N Y Acad Sci 1183, 89–103.
16. Martinez J, Huang X, Yang Y. (2010) Toll-like receptor 8-mediated activation of murine plasmacytoid dendritic cells by vaccinia viral DNA Proceedings of the National Academy of Sciences 107, 6442–6447.
17. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. (2000) A Toll-like receptor recognizes bacterial DNA Nature 408, 740–745.
18. Kawai T, Akira S. (2007) Antiviral signaling through pattern recognition receptors Journal of Biochemistry 141, 137–145.
19. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, et al. (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway Science 301, 640–643.
20. Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, et al. (2006) Critical role of TRAF3 in the Toll-like receptor-dependent and-independent antiviral response Nature 439, 208–211.
21. Seya T, Shime H, Ebihara T, Oshiumi H, Matsumoto M. (2010) Pattern recognition receptors of innate immunity and their application to tumor immunotherapy. Cancer Sci 101(2), 313–320.
22. Kawai T, Akira S. (2007) TLR signaling Seminars in Immunology 19, 24–32.
23. Hornung V, Schlender J, Guenthner-Biller M, Rothenfusser S, Endres S, et al. (2004) Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virus J Immunol 173, 5935–5943.
24. Uematsu S, Akira S. (2006) Toll-like receptors and innate immunity J Mol Med 84, 712–725.
25. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, et al. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses Nature 434, 772–777.
26. Yoneyama M, Fujita T. (2007) RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity Cytokine & Growth Factor Reviews 18, 545–551.
27. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, et al. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses Nature 441, 101–105.
28. Hornung V, Ellegast J, Kim S, Brzózka K, Jung A, et al. (2006) 5’-Triphosphate RNA is the ligand for RIG-I Science 314, 994–997.
29. Scott I, Norris KL. (2008) The mitochondrial antiviral signaling protein, MAVS, is cleaved during apoptosis Biochemical and Biophysical Research Communications 375, 101–106.
30. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus Nature 437, 1167–1172.
31. Sharma S, tenOever BR, Grandvaux N, Zhou G-P, Lin R, et al. (2003) Triggering the interferon antiviral response through an IKK-related pathway Science 300, 1148–1151.
32. Balachandran S, Thomas E, Barber GN. (2004) A FADD-dependent innate immune mechanism in mammalian cells Nature 432, 401–405.
33. Balachandran S, Venkataraman T, Fisher PB, Barber GN. (2007) Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7 J Immunol 178, 2429–2439.
34. Martin D, Gutkind JS. (2008) Human tumor-associated viruses and new insights into the molecular mechanisms of cancer Oncogene 27 Suppl 2, S31–42.
35. Stetson DB, Medzhitov R. (2006) Recognition of cytosolic DNA activates an IRF3-dependent innate immune response Immunity 24, 93–103.
36. Wang Z, Choi MK, Ban T, Yanai H, Negishi H, et al. (2008) Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules Proc Natl Acad Sci USA 105, 5477–5482.
37. Ishikawa H, Barber GN. (2008) STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling Nature 455, 674–678.
38. Ishikawa H, Ma Z, Barber GN. (2009) STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity Nature 461, 788–792.
39. Constantinescu SN, Girardot M, Pecquet C. (2008) Mining for JAK-STAT mutations in cancer Trends Biochem Sci 33, 122–131.
40. Zou W, Kim J-H, Handidu A, Li X, Kim KI, et al. (2007) Microarray analysis reveals that Type I interferon strongly increases the expression of immune-response related genes in Ubp43 (Usp18) deficient macrophages Biochemical and Biophysical Research Communications 356, 193–199.
41. Platanias LC, Fish EN. (1999) Signaling pathways activated by interferons Exp Hematol 27, 1583–1592.
42. Darnell JE. (1997) STATs and gene regulation Science 277, 1630–1635.
43. Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, et al. (2006) Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity Immunity 25: 745–755.
44. Schindler C, Levy DE, Decker T. (2007) JAK-STAT signaling: from interferons to cytokines J Biol Chem 282, 20059–20063.
45. Platanias LC. (2005) Mechanisms of type-I-and type-II-interferon-mediated signalling Nat Rev Immunol 5, 375–386.
46. Joshi S, Kaur S, Kroczynska B, Platanias LC. (2010) Mechanisms of mRNA translation of interferon stimulated genes. Cytokine.
47. Balachandran S, Barber GN. (2004) Defective translational control facilitates vesicular stomatitis virus oncolysis Cancer Cell 5, 51–65.
48. Pfeifer I, Elsby R, Fernandez M, Faria PA, Nussenzveig DR, et al. (2008) NFAR-1 and-2 modulate translation and are required for efficient host defense Proc Natl Acad Sci USA 105, 4173–4178.
49. Colina R, Costa-Mattioli M, Dowling RJO, Jaramillo M, Tai L-H, et al. (2008) Translational control of the innate immune response through IRF-7 Nature 452, 323–328.
50. Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, et al. (2003) Integration of inter-feron-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence Nature 424, 516–523.
51. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, et al. (2007) Interferon modulation of cellular microRNAs as an antiviral mechanism Nature 449, 919–922.
52. Ohno M, Natsume A, Kondo Y, Iwamizu H, Motomura K, et al. (2009) The modulation of microRNAs by type I IFN through the activation of signal transducers and activators of transcription 3 in human glioma Mol Cancer Res 7, 2022–2030.
53. Jarmalaite S, Andrekute R, Scesnaite A, Suziedelis K, Husgafvel-Pursiainen K, et al. (2010) Promoter hypermethylation in tumour suppressor genes and response to interleukin-2 treatment in bladder cancer: a pilot study J Cancer Res Clin Oncol 136, 847–854.
54. Marozin S, Altomonte J, Stadler F, Thasler WE, Schmid RM, et al. (2008) Inhibition of the IFN-beta response in hepatocellular carcinoma by alternative spliced isoform of IFN regulatory factor-3 Mol Ther 16, 1789–1797.
55. Jee CD, Kim MA, Jung EJ, Kim J, Kim WH. (2009) Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma Eur J Cancer 45, 1282–1293.
56. Almeida S, Maillard C, Itin P, Hohl D, Huber M. (2008) Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deu-biquitinase activity J Invest Dermatol 128, 587–593.
57. Critchley-Thorne RJ, Yan N, Nacu S, Weber J, Holmes SP, et al. (2007) Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma PLoS Med 4, e176.
58. Pansky A, Hildebrand P, Fasler-Kan E, Baselgia L, Ketterer S, et al. (2000) Defective Jak-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-alpha Int J Cancer 85, 720–725.
59. Mullighan CG, Zhang J, Harvey RC, Collins-Underwood JR, Schulman BA, et al. (2009) JAK mutations in high-risk childhood acute lymphoblastic leukemia Proc Natl Acad Sci USA 106, 9414–9418.
60. van Eyndhoven WG, Gamper CJ, Cho E, Mackus WJ, Lederman S. (1999) TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-kappaB activation Molecular Immunology 36, 647–658.
61. Nagel I, Bug S, Tönnies H, Ammerpohl O, Richter J, et al. (2009) Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33) Leukemia 23, 2153–2155.
62. Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, et al. (2009) Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 Nature 462, 108–112.